Navigation Links
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
Date:11/26/2007

TORISEL Extends Median Overall Survival vs. Interferon-Alpha

COLLEGEVILLE, Pa., Nov. 26 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the European Commission has approved TORISEL(TM) (temsirolimus) for the first-line treatment of patients with advanced renal cell carcinoma (RCC) who have at least three of six prognostic risk factors. TORISEL is the only approved cancer therapy that specifically inhibits the mTOR (mammalian target of rapamycin) kinase, an important regulator of cell proliferation, cell growth and cell survival. TORISEL was approved in the United States in May 2007 for the treatment of advanced RCC.

Renal cell carcinoma accounts for approximately 85 percent of the estimated 85,000 new cases of kidney cancer diagnosed in Europe annually. TORISEL is the only renal cancer therapy proved to extend median overall survival compared with interferon-alpha in patients with advanced RCC.

"Temsirolimus was studied in the most difficult-to-treat patients with advanced renal cell carcinoma: those who have multiple risk factors that have been associated with shortened survival," says Bernard Escudier, M.D., Head of the Immunotherapy Unit, Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France, and an investigator in the TORISEL phase 3 study. "The ability of temsirolimus to provide an increase in overall survival in these patients provides us with a much-needed new option for the treatment of advanced kidney cancer."

TORISEL was studied in a three-arm, phase 3 clinical trial of 626 patients with advanced RCC and three or more of six preselected prognostic risk factors who had received no prior systemic therapy.
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... ATLANTA , April 24, 2015 Allowing ... naloxone could reduce drug overdose deaths that involve opioids, ... (CDC) study, "Disparity in Naloxone Administration by Emergency Medical ... Rural Communities," published in the American Journal of ... 16,000 deaths in the United States ...
(Date:4/24/2015)... , April 24, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, announced the Company ... on Tuesday, April 28, 2015 to discuss the 1st ... to listen to the call by dialing 1-888-346-3479. International ... Participants should ask to be joined into the IGI ...
(Date:4/24/2015)... , April 24, 2015   Vestagen Technical ... technology, VESTEX ® , has recently received two notable ... a global competition that recognizes innovations with potential to ... ceremony last night in New York City ... the Material Science "Protection & Safety" category. The awards ...
Breaking Medicine Technology:Expanding Naloxone use could reduce drug overdose deaths and save lives 2Expanding Naloxone use could reduce drug overdose deaths and save lives 3VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3
... 8, 2011 Novation, the leading health care supply ... Medical (St. Paul, MN) to its portfolio of agreements ... Jude Medical is a leading provider of medical devices ... company provides a full portfolio of arrhythmia management products, ...
... HOFFMAN ESTATES, Ill., April 8, 2011 Life Spine, ... markets products for the surgical treatment of spine disorders, ... out of nine new products scheduled for launch in ... (AANS) Annual Meeting in Denver, Colorado. ...
Cached Medicine Technology:Novation Announces the Addition of St. Jude Medical to the Cardiac Rhythm Management Products Portfolio 2
(Date:4/24/2015)... New York, New York (PRWEB) April 24, 2015 ... continue to move forward in the federal ... of South Carolina. According to court documents, the ... Status Report on April 16th detailing, among other ... The report notes that counsel for both plaintiffs ...
(Date:4/24/2015)... April 24, 2015 The first step ... the mind. , For meditation and yoga teacher Stine ... have been invaluable tools that allow her to experience ... She has been a teacher since 2006, and through ... inner state of being. , “I love sharing this ...
(Date:4/24/2015)... Anchor Health Administrators (Anchor), specialists in ... announced their exclusive agreement with LTC Solutions for All ... distribution partner. , Anchor has more than 18 years ... for associations, and is currently the designated advocate for ... Care Insurance member benefit. , “I am very pleased ...
(Date:4/24/2015)... “Kind,” “selfless,” “the voice of reason” and ... Weiner described pediatric oncology nurse Laura Vasquez of Children’s ... during her five-year battle with a malignant brain tumor. ... and numerous experimental treatments, Vasquez continued caring for Alexa, ... was not in the hospital and even sitting vigil ...
(Date:4/24/2015)... 2015 National Access Cannabis ... access to medical cannabis, is taking a leadership role ... advising patients. , NAC is the first to back ... $250,000 grant, NAC will be providing 300 healthcare professionals ... is to help Canadians gain safe and responsible access ...
Breaking Medicine News(10 mins):Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 4Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2
... 5 Longs Drug,Stores Corporation (NYSE: LDG ... the fourth quarter ended January 31, 2008, a,14-week ... share, including a,$1.1 million after-tax net gain related ... from continuing operations for the fourth quarter,ended January ...
... of assessment,and improvement activities for individual physician practices, ... of,Medical Specialties (ABMS) announced today that Blue Cross ... ABMS Patient Safety Improvement,Program to HMO and PPO ... and safety in patient care. BCBSIL is the ...
... March 5 Medifast, Inc.,(NYSE: MED ) announced today ... for the period ended December 31, 2007 on,Wednesday, March 12, ... call and webcast to discuss the results on Thursday, March ... the call by dialing (877) 407-0782 or,(201) 689-8567, or can ...
... first, study finds , , WEDNESDAY, March 5 (HealthDay News) -- ... more likely to become pregnant again within two years of ... study. , The study followed 269 predominately black American, low-income ... five community sites. One or two years after giving birth, ...
... Cancer Society, the American College of Radiology, and ... (a group that comprises representatives from the American ... Society for Gastrointestinal Endoscopy) have released the first-ever ... guidelines add two new tests to the list ...
... when abusive parents with multiple children target just one ... the abused child from the home and return the ... children can suffer lifelong emotional scars from helping parents ... forced to participate in torturing their siblings, according to ...
Cached Medicine News:Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 2Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 3Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 4Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 5Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 6Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 7Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 8Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 9Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 10Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 11Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 12Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 13Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 14Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 15Health News:Blue Cross and Blue Shield of Illinois to Offer ABMS(R) Patient Safety Improvement Program to Network Physicians 2Health News:Blue Cross and Blue Shield of Illinois to Offer ABMS(R) Patient Safety Improvement Program to Network Physicians 3Health News:Medifast, Inc. to Announce Fourth Quarter and Fiscal Year-End Results on Wednesday, March 12, 2008 2Health News:Depression Raised Risk of Subsequent Pregnancies Among Black Teen Moms 2Health News:Health groups issue updated colorectal cancer screening guidelines 2Health News:Health groups issue updated colorectal cancer screening guidelines 3Health News:Authorities fail to recognize emotionally scarred brothers and sisters of child abuse victims 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: